Minimizing Disruptions to Continuity of Care

In the fifth of our six-part series examining the prior authorization (PA) process in Canada vs. the U.S. we address the importance of the continuity of patient care.
The Implication of New Changes for Prior Authorization in the U.S.

Changes in prior authorization are now coming to the U.S. at the federal level. What does this mean for Canada?
Improving the Road Map to Patient Support Programs and Reimbursement

As a former Oncology Drug Access Navigator (DAN), I understood that my patients needed treatment urgently for their cancer, and they didn’t have time to wait for it […]
Prior Authorization Program Review and Volume Adjustment

In the fourth of our six-part series on comparing the PA process in Canada vs. the U.S. we address the importance of regular prior authorization program review.
What Is Selective Application of Prior Authorization and What Does It Mean to Stakeholders?

In this third in our six-part series on prior authorization (PA) in Canada vs the U.S. we address the selective application of PA.
Lessons for Canada on Prior Authorization Reform: An American Experience

Since 2020, the conversation around improving the prior authorization process and experience has been gaining traction in Canada. Learn what Canadian stakeholders can take away from American developments.
The First Prior Authorization Resource for Prescribers

Are you a physician, pharmacist, or other prescriber that has patients with a prescription for specialty medications? If you are, it’s likely that your patients have a prescription for a therapy or medication that requires prior authorization, and they probably have questions about it.
The First Prior Authorization Resource for Patient Support Programs

Do you represent a patient support/assistance program (PSP/PAP)? If you do, it’s likely that the patients you help have a prescription for a therapy or medication that requires prior authorization, and they probably have questions about it.
June is Migraine Awareness Month – How ePA can help patients and payers manage migraine

Advancements in medical research have yielded innovative medications in recent years and can significantly improve the lives of those living with migraine.
Look Who is On Board With the Simplify Prior Authorization Initiative

The Simplify Prior Authorization (SPA) initiative is pleased to announce that Innomar Strategies has joined the growing list of organizations working together for an improved prior authorization process.